Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals.

流感病毒疫苗接种在老年人中引起的B细胞反应适应性较差

阅读:4
作者:Henry Carole, Zheng Nai-Ying, Huang Min, Cabanov Alexandra, Rojas Karla Thatcher, Kaur Kaval, Andrews Sarah F, Palm Anna-Karin E, Chen Yao-Qing, Li Yang, Hoskova Katerina, Utset Henry A, Vieira Marcos C, Wrammert Jens, Ahmed Rafi, Holden-Wiltse Jeanne, Topham David J, Treanor John J, Ertl Hildegund C, Schmader Kenneth E, Cobey Sarah, Krammer Florian, Hensley Scott E, Greenberg Harry, He Xiao-Song, Wilson Patrick C
Influenza is a leading cause of death in the elderly, and the vaccine protects only a fraction of this population. A key aspect of antibody-mediated anti-influenza virus immunity is adaptation to antigenically distinct epitopes on emerging strains. We examined factors contributing to reduced influenza vaccine efficacy in the elderly and uncovered a dramatic reduction in the accumulation of de novo immunoglobulin gene somatic mutations upon vaccination. This reduction is associated with a significant decrease in the capacity of antibodies to target the viral glycoprotein, hemagglutinin (HA), and critical protective epitopes surrounding the HA receptor-binding domain. Immune escape by antigenic drift, in which viruses generate mutations in key antigenic epitopes, becomes highly exaggerated. Because of this reduced adaptability, most B cells activated in the elderly cohort target highly conserved but less potent epitopes. Given these findings, vaccines driving immunoglobulin gene somatic hypermutation should be a priority to protect elderly individuals.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。